Aptevo Therapeutics Inc.
USD4.35
-0.20 (-4.40%)
CEO
Jeffrey G. Lamothe
IPO Date
2016-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.42
Prev. Close
$4.55
Day Low
$4.35
Day High
$4.52
52W Low
$3.80
52W High
$59.40
Market Cap
$0.01B
Volume
0.12M
| -0.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -142.5% | -70.1% | 0.44 | 2.64 | -0.1 |
| 31 Dec 2022 | FY | 100.0% | 257.8% | 44.7% | 23.5% | 0.53 | 3.15 | 1.5 |
| 31 Dec 2021 | FY | 100.0% | -231.5% | -2340.2% | -50.3% | 13.75 | 1.51 | -1.3 |
| 31 Dec 2020 | FY | -314.3% | -411.9% | -107.0% | -33.1% | 1.65 | 3.25 | -7.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -377.5% | -83.7% | 1.96 | 0.78 | 0.0 |
| 31 Dec 2018 | FY | 51.4% | -232.8% | -176.6% | -79.5% | 0.63 | 2.76 | 0.0 |
| 31 Dec 2017 | FY | 65.8% | 47.6% | 8.5% | 6.0% | 0.23 | 5.14 | 0.0 |
| 31 Dec 2016 | FY | 33.6% | -308.5% | -222.3% | -122.4% | 0.36 | 3.65 | 0.0 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -43.4% | -28.0% | 0.23 | 4.03 | -0.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -95.1% | -39.7% | 0.65 | 2.27 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 435.0% | -76.8% | -3.00 | 0.67 | -0.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -132.7% | -40.5% | 0.97 | 1.72 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -115.4% | -33.7% | 1.09 | 1.70 | -0.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -131.8% | -39.4% | 1.13 | 1.77 | -0.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -112.0% | -38.8% | 0.85 | 1.92 | -0.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -48.3% | -23.8% | 0.44 | 2.64 | -0.1 |